The CRISPR/dCas9 system was employed to elucidate the significance of transcription factor binding on MYCN locus, and found that the inhibition of OCT4 binding was found to be critical for MYCN expression in MYCN-amplified NB. Here, POU5F1 is linked to neuroblastoma.